Company
Edgewise Therapeutics, Inc.
EWTX · CIK 0001710072
Acquisition (code M) of 17,969 shares at $0.00 per share.
Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code M
Traded Aug 12, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →
Acquisition (code M) of 21,875 shares at $0.00 per share.
Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code M
Traded Aug 12, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →
Sale of 8,782 shares at $43.6408 per share.
Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code S
Traded Aug 12, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →
Sale of 8,276 shares at $43.6582 per share.
Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code S
Traded Aug 12, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →
Sale of 913 shares at $44.33 per share.
Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code S
Traded Aug 12, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →